Literature DB >> 15022132

Exercise testing and training in German CF centers.

Michael Barker1, Alexandra Hebestreit, Wolfgang Gruber, Helge Hebestreit.   

Abstract

Physical exercise is increasingly recognized as a valuable diagnostic and therapeutic modality for patients with cystic fibrosis (CF). We sought to characterize the use of exercise testing and training as well as the attitude toward both issues through a national survey. A questionnaire was sent to 107 specialized CF centers (caring for a total of 5,231 patients) and 7 inpatient rehabilitation institutions. Answers were available from 62 specialized centers caring for 3,580 patients and from 4 rehabilitation centers with 520 treatment episodes per year. Sixty percent of specialized centers performed some sort of exercise testing at an average frequency of 1 in 2.3 years for patients aged 8 and above. However, protocols and indication criteria were often unstandardized or not specified at all. Equipment availability was no major problem, and the majority of tests were conducted by a physician alone. Nineteen centers had adopted exercise testing as part of their diagnostic routine. Two thirds of caregivers advised their patients to engage in physical activity, but failed to discuss specific modalities and potential hazards. Nevertheless, physical exercise was viewed as "extremely important" or "very important" by 87%. In a rehabilitation setting, an exercise test was conducted 1.1 times per patient stay, and a training program offered in 100% of cases. In conclusion, standardized exercise testing and training programs appear to be underused in German CF centers, despite a high degree of interest in the topic. Supplementary material for this article can be found on the Pediatric Pulmonology website (http//www.interscience.wiley.com/jpages/8755-6863/suppmat). Copyright 2004 Wiely-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15022132     DOI: 10.1002/ppul.10430

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  7 in total

1.  Measurement properties of the one-minute sit-to-stand test in children and adolescents with cystic fibrosis: A multicenter randomized cross-over trial.

Authors:  Yann Combret; Fairuz Boujibar; Charlotte Gennari; Clément Medrinal; Sophie Sicinski; Tristan Bonnevie; Francis-Edouard Gravier; Muriel Laurans; Christophe Marguet; Pascal Le Roux; Bouchra Lamia; Guillaume Prieur; Grégory Reychler
Journal:  PLoS One       Date:  2021-02-12       Impact factor: 3.240

2.  Exercise training in children and adolescents with cystic fibrosis: theory into practice.

Authors:  Craig A Williams; Christian Benden; Daniel Stevens; Thomas Radtke
Journal:  Int J Pediatr       Date:  2010-09-19

Review 3.  Exercise testing and training with the young cystic fibrosis patient.

Authors:  Daniel Stevens; Craig A Williams
Journal:  J Sports Sci Med       Date:  2007-09-01       Impact factor: 2.988

4.  Tele-Exercise as a Promising Tool to Promote Exercise in Children With Cystic Fibrosis.

Authors:  Jen Jen Chen; Dan M Cooper; Fadia Haddad; Anna Sladkey; Eliezer Nussbaum; Shlomit Radom-Aizik
Journal:  Front Public Health       Date:  2018-09-28

5.  Does Pseudomonas aeruginosa Colonization Affect Exercise Capacity in CF?

Authors:  Asterios Kampouras; Elpis Hatziagorou; Vasiliki Avramidou; Vasiliki Georgopoulou; Fotios Kirvassilis; John Tsanakas
Journal:  Pulm Med       Date:  2019-12-09

6.  Effects of a Partially Supervised Conditioning Program in Cystic Fibrosis: An International Multicenter, Randomized Controlled Trial (ACTIVATE-CF).

Authors:  Helge Hebestreit; Susi Kriemler; Christian Schindler; Lothar Stein; Chantal Karila; Don S Urquhart; David M Orenstein; Larry C Lands; Jonathan Schaeff; Ernst Eber; Thomas Radtke
Journal:  Am J Respir Crit Care Med       Date:  2022-02-01       Impact factor: 21.405

7.  Recommendations to improve physical activity prescription for the cystic fibrosis population: an Irish perspective.

Authors:  Nicola Hurley; Bróna Kehoe; Noel McCaffrey; Karen Redmond; Lydia Cullen; Niall M Moyna
Journal:  BMC Health Serv Res       Date:  2020-11-19       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.